The Latest Breaking News on Pharma

"Over the course of this critical year, we hope to launch as many as four new medicines for challenging diseases, while advancing our next generation of molecules currently in Phase 3." said CEO David Ricks.

Merck said it sees 2023 sales in the region of $57.2 billion and $58.7 billion.

A small Dallas biotech company and the University of Texas took on big pharma and won.

Watch: The funeral for controversial Cardinal George Pell is underway. An urgent report into alcohol restrictions in Alice Springs is expected to

Merck & Co.’s COVID-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s genetic code.

DC boss James Gunn has addressed a controversial tweet from Zachary Levi that called into question the "Shazam!" star's position on vaccines.

CNBC's Jim Cramer has a lot to say about Wegovy, Novo Nordisk's fast-selling weight loss treatment.

Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

GSK stock and NVO stock rose Wednesday, though both beat forecasts. Novartis stock skidded on lighter-than-expected sales.

The Ministry of Public Health will press ahead with a controversial amendment that would make possession of more than one methamphetamine pill dealing in illegal narcotics.